In ₹ Crore except Per Share Latest Annual	NEPHROPLUS FY26	KRSNAA FY26	SURAKSHA FY26	HEALTHX FY26	Peer Average
Valuation — at last close
P/E	74.12×	◆ 15.91×	51.71×	754.59×	274.07× -73%
P/B	5.65×	1.65×	6.80×	◆ 1.39×	3.28× +72%
EV/EBITDA	26.26×	8.44×	17.17×	◆ -19.27×	2.11× +1142%
Market Cap	₹6,307 Cr	₹1,615 Cr	₹1,664 Cr	₹888 Cr	₹1,389 Cr +354%
Growth
Revenue CAGR 3Y	—	◆ 16.63%	—	8.26%	12.45%
Revenue CAGR 5Y	—	—	—	19.20%	19.20%
Net Income CAGR 3Y	—	17.76%	—	—	17.76%
Revenue YoY (latest Q)	—	22.05%	20.75%	◆ 49.73%	30.84%
Net Income YoY (latest Q)	—	-19.34%	◆ 40.00%	-92.53%	-23.96%
Profitability
EBITDA Margin	22.72%	27.42%	◆ 30.73%	-3.95%	18.07% +26%
Net Income Margin	7.69%	◆ 13.13%	10.12%	-0.11%	7.71% 0%
Return on Common Equity	6.88%	10.89%	◆ 14.11%	0.18%	8.39% -18%
Return on Capital Employed	11.63%	9.62%	◆ 15.88%	—	12.75% -9%
Return on Assets	5.22%	6.53%	◆ 8.04%	-0.15%	4.81% +9%
Credit & Quality
Total Debt/Equity	0.07×	0.55×	◆ 0.01×	0.03×	0.20× -64%
Interest Coverage	2.26×	3.53×	◆ 4.30×	-75.12×	-22.43× +110%
Scale — latest FY
Revenue / Total Income	₹999 Cr	₹773 Cr	₹310 Cr	₹1,319 Cr	₹801 Cr +25%
Net Income	₹76.8 Cr	₹101 Cr	₹31.4 Cr	−₹1.4 Cr	₹43.8 Cr +75%
Total Assets	₹1,471 Cr	₹1,824 Cr	₹448 Cr	₹936 Cr	₹1,069 Cr +38%
EPS	₹8.48	₹31.3	₹6.18	₹0.37	₹12.62 -33%
Book Value per Share	₹111.27	₹302.23	₹47.01	₹201.47	₹183.57 -39%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.